Back to Results
First PageMeta Content
Cytokines / Cancer organizations / Immunotherapy / Cancer immunotherapy / Interleukin 7 / Cancer vaccine / Cancer research / Fred Hutchinson Cancer Research Center / Interleukin / Medicine / Immunology / Cancer treatments


Microsoft Word - Cytheris_CITN_110517.doc
Add to Reading List

Document Date: 2013-11-15 15:23:27

Open Document

File Size: 285,89 KB

Share Result on Facebook

City

Seattle / Rockville / Bethesda / Lyon / Paris / /

Company

Cytheris SA / Andrew Lloyd & Associates / /

Continent

North America / Europe / /

Country

Taiwan / United States / Canada / South Africa / /

/

Facility

US National Cancer Institute / National Cancer Institute / Fred Hutchinson Cancer Research Center / /

IndustryTerm

stage biopharmaceutical / immune systems / biopharmaceutical / treatment of cancer / treatment of various cancers / media inquiries / /

MedicalCondition

cancers / similar genetic tumors / Cancer / HIV / bacterial infections / tumors / HBV / Ewing's sarcoma / HCV / metastatic breast cancer / /

MedicalTreatment

chemotherapy / radiotherapy / immunotherapy / /

Organization

National Cancer Institute / Hutchinson Center’s Clinical Research Division / Central Operations and Statistical Center / French Bettencourt Schueller Foundation / Cancer Immunotherapy Trials Network / Fred Hutchinson Cancer Research Center / /

Person

Michel Morre / Neil Hunter / /

/

Position

Principal Investigator / director / President and CEO / /

ProvinceOrState

Maryland / Washington / /

Technology

chemotherapy / transplantation / drug development / /

URL

www.cytheris.com / www.CITNinfo.org / /

SocialTag